IBDEI0IV ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25507,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,25507,1,5,0)
 ;;=5^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,25507,2)
 ;;=^107916
 ;;^UTILITY(U,$J,358.3,25508,0)
 ;;=710.1^^136^1539^14
 ;;^UTILITY(U,$J,358.3,25508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25508,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,25508,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,25508,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,25509,0)
 ;;=995.20^^136^1539^1
 ;;^UTILITY(U,$J,358.3,25509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25509,1,4,0)
 ;;=4^995.20
 ;;^UTILITY(U,$J,358.3,25509,1,5,0)
 ;;=5^Adverse Effects of Meds
 ;;^UTILITY(U,$J,358.3,25509,2)
 ;;=^334208
 ;;^UTILITY(U,$J,358.3,25510,0)
 ;;=V67.51^^136^1539^6
 ;;^UTILITY(U,$J,358.3,25510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25510,1,4,0)
 ;;=4^V67.51
 ;;^UTILITY(U,$J,358.3,25510,1,5,0)
 ;;=5^Hi-Risk F/U Exam
 ;;^UTILITY(U,$J,358.3,25510,2)
 ;;=^295577
 ;;^UTILITY(U,$J,358.3,25511,0)
 ;;=136.1^^136^1540^1
 ;;^UTILITY(U,$J,358.3,25511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25511,1,4,0)
 ;;=4^136.1
 ;;^UTILITY(U,$J,358.3,25511,1,5,0)
 ;;=5^Behcet's Syndrome
 ;;^UTILITY(U,$J,358.3,25511,2)
 ;;=^13205
 ;;^UTILITY(U,$J,358.3,25512,0)
 ;;=710.3^^136^1540^2
 ;;^UTILITY(U,$J,358.3,25512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25512,1,4,0)
 ;;=4^710.3
 ;;^UTILITY(U,$J,358.3,25512,1,5,0)
 ;;=5^Dermatomyositis
 ;;^UTILITY(U,$J,358.3,25512,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,25513,0)
 ;;=710.9^^136^1540^3
 ;;^UTILITY(U,$J,358.3,25513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25513,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,25513,1,5,0)
 ;;=5^Diff Connect Tis Dis NOS
 ;;^UTILITY(U,$J,358.3,25513,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,25514,0)
 ;;=710.5^^136^1540^4
 ;;^UTILITY(U,$J,358.3,25514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25514,1,4,0)
 ;;=4^710.5
 ;;^UTILITY(U,$J,358.3,25514,1,5,0)
 ;;=5^Eosinophilia Myalgia
 ;;^UTILITY(U,$J,358.3,25514,2)
 ;;=^184796
 ;;^UTILITY(U,$J,358.3,25515,0)
 ;;=710.8^^136^1540^5
 ;;^UTILITY(U,$J,358.3,25515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25515,1,4,0)
 ;;=4^710.8
 ;;^UTILITY(U,$J,358.3,25515,1,5,0)
 ;;=5^Mixed Connect Tis Dis NEC
 ;;^UTILITY(U,$J,358.3,25515,2)
 ;;=^271945
 ;;^UTILITY(U,$J,358.3,25516,0)
 ;;=710.4^^136^1540^6
 ;;^UTILITY(U,$J,358.3,25516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25516,1,4,0)
 ;;=4^710.4
 ;;^UTILITY(U,$J,358.3,25516,1,5,0)
 ;;=5^Polymyositis
 ;;^UTILITY(U,$J,358.3,25516,2)
 ;;=^186822
 ;;^UTILITY(U,$J,358.3,25517,0)
 ;;=710.2^^136^1540^7
 ;;^UTILITY(U,$J,358.3,25517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25517,1,4,0)
 ;;=4^710.2
 ;;^UTILITY(U,$J,358.3,25517,1,5,0)
 ;;=5^Sjogren Syndrome
 ;;^UTILITY(U,$J,358.3,25517,2)
 ;;=^192145
 ;;^UTILITY(U,$J,358.3,25518,0)
 ;;=710.0^^136^1540^8
 ;;^UTILITY(U,$J,358.3,25518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25518,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,25518,1,5,0)
 ;;=5^Syst Lupus Erythematosis
 ;;^UTILITY(U,$J,358.3,25518,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,25519,0)
 ;;=710.1^^136^1540^9
 ;;^UTILITY(U,$J,358.3,25519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25519,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,25519,1,5,0)
 ;;=5^Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,25519,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,25520,0)
 ;;=90471^^137^1541^1^^^^1
 ;;^UTILITY(U,$J,358.3,25520,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25520,1,2,0)
 ;;=2^90471
 ;;^UTILITY(U,$J,358.3,25520,1,3,0)
 ;;=3^Immunization Admin (use w/ Vaccs)
 ;;^UTILITY(U,$J,358.3,25521,0)
 ;;=90472^^137^1541^2^^^^1
 ;;^UTILITY(U,$J,358.3,25521,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25521,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,25521,1,3,0)
 ;;=3^Immunization Admin, ea add
 ;;^UTILITY(U,$J,358.3,25522,0)
 ;;=90632^^137^1541^6^^^^1
 ;;^UTILITY(U,$J,358.3,25522,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25522,1,2,0)
 ;;=2^90632
 ;;^UTILITY(U,$J,358.3,25522,1,3,0)
 ;;=3^Hepatitis A Vaccine
 ;;^UTILITY(U,$J,358.3,25523,0)
 ;;=90746^^137^1541^7^^^^1
 ;;^UTILITY(U,$J,358.3,25523,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25523,1,2,0)
 ;;=2^90746
 ;;^UTILITY(U,$J,358.3,25523,1,3,0)
 ;;=3^Hepatitis B Vaccine (3 Doses)
 ;;^UTILITY(U,$J,358.3,25524,0)
 ;;=90636^^137^1541^8^^^^1
 ;;^UTILITY(U,$J,358.3,25524,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25524,1,2,0)
 ;;=2^90636
 ;;^UTILITY(U,$J,358.3,25524,1,3,0)
 ;;=3^Hepatitis A&B Vaccine
 ;;^UTILITY(U,$J,358.3,25525,0)
 ;;=90707^^137^1541^9^^^^1
 ;;^UTILITY(U,$J,358.3,25525,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25525,1,2,0)
 ;;=2^90707
 ;;^UTILITY(U,$J,358.3,25525,1,3,0)
 ;;=3^MMR Virus
 ;;^UTILITY(U,$J,358.3,25526,0)
 ;;=90658^^137^1541^3^^^^1
 ;;^UTILITY(U,$J,358.3,25526,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25526,1,2,0)
 ;;=2^90658
 ;;^UTILITY(U,$J,358.3,25526,1,3,0)
 ;;=3^Flu Vaccine IM (Flulaval)
 ;;^UTILITY(U,$J,358.3,25527,0)
 ;;=90732^^137^1541^10^^^^1
 ;;^UTILITY(U,$J,358.3,25527,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25527,1,2,0)
 ;;=2^90732
 ;;^UTILITY(U,$J,358.3,25527,1,3,0)
 ;;=3^Pneumococcal Vaccine
 ;;^UTILITY(U,$J,358.3,25528,0)
 ;;=90715^^137^1541^12^^^^1
 ;;^UTILITY(U,$J,358.3,25528,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25528,1,2,0)
 ;;=2^90715
 ;;^UTILITY(U,$J,358.3,25528,1,3,0)
 ;;=3^TDaP Vaccine
 ;;^UTILITY(U,$J,358.3,25529,0)
 ;;=90736^^137^1541^13^^^^1
 ;;^UTILITY(U,$J,358.3,25529,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25529,1,2,0)
 ;;=2^90736
 ;;^UTILITY(U,$J,358.3,25529,1,3,0)
 ;;=3^Zoster (Shingles) Vaccine
 ;;^UTILITY(U,$J,358.3,25530,0)
 ;;=90714^^137^1541^11^^^^1
 ;;^UTILITY(U,$J,358.3,25530,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25530,1,2,0)
 ;;=2^90714
 ;;^UTILITY(U,$J,358.3,25530,1,3,0)
 ;;=3^TD Vaccine
 ;;^UTILITY(U,$J,358.3,25531,0)
 ;;=90656^^137^1541^4^^^^1
 ;;^UTILITY(U,$J,358.3,25531,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25531,1,2,0)
 ;;=2^90656
 ;;^UTILITY(U,$J,358.3,25531,1,3,0)
 ;;=3^Flu Vaccine Single Dose Syringe (Afluria)
 ;;^UTILITY(U,$J,358.3,25532,0)
 ;;=90662^^137^1541^5^^^^1
 ;;^UTILITY(U,$J,358.3,25532,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25532,1,2,0)
 ;;=2^90662
 ;;^UTILITY(U,$J,358.3,25532,1,3,0)
 ;;=3^Flu Vaccine High Dose Syringe (Fluzone)
 ;;^UTILITY(U,$J,358.3,25533,0)
 ;;=96372^^137^1542^1^^^^1
 ;;^UTILITY(U,$J,358.3,25533,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25533,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,25533,1,3,0)
 ;;=3^Ther/Proph/Dx Inj SQ/IM
 ;;^UTILITY(U,$J,358.3,25534,0)
 ;;=20600^^137^1542^2^^^^1
 ;;^UTILITY(U,$J,358.3,25534,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25534,1,2,0)
 ;;=2^20600
 ;;^UTILITY(U,$J,358.3,25534,1,3,0)
 ;;=3^Drain/Inject Small Joint/Bursa
 ;;^UTILITY(U,$J,358.3,25535,0)
 ;;=20605^^137^1542^3^^^^1
 ;;^UTILITY(U,$J,358.3,25535,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25535,1,2,0)
 ;;=2^20605
 ;;^UTILITY(U,$J,358.3,25535,1,3,0)
 ;;=3^Drain/Inject Interm Joint/Bursa
 ;;^UTILITY(U,$J,358.3,25536,0)
 ;;=20610^^137^1542^4^^^^1
 ;;^UTILITY(U,$J,358.3,25536,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25536,1,2,0)
 ;;=2^20610
 ;;^UTILITY(U,$J,358.3,25536,1,3,0)
 ;;=3^Drain/Inject Major Joint/Bursa
 ;;^UTILITY(U,$J,358.3,25537,0)
 ;;=99078^^137^1543^2^^^^1
 ;;^UTILITY(U,$J,358.3,25537,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25537,1,2,0)
 ;;=2^99078
 ;;^UTILITY(U,$J,358.3,25537,1,3,0)
 ;;=3^Group Health Education
 ;;^UTILITY(U,$J,358.3,25538,0)
 ;;=98960^^137^1543^3^^^^1
 ;;^UTILITY(U,$J,358.3,25538,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25538,1,2,0)
 ;;=2^98960
 ;;^UTILITY(U,$J,358.3,25538,1,3,0)
 ;;=3^Self-Mgmt Educ/Train 1 Pt
 ;;^UTILITY(U,$J,358.3,25539,0)
 ;;=98961^^137^1543^4^^^^1
 ;;^UTILITY(U,$J,358.3,25539,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25539,1,2,0)
 ;;=2^98961
 ;;^UTILITY(U,$J,358.3,25539,1,3,0)
 ;;=3^Self-Mgmt Educ/Train 2-4 Pt
 ;;^UTILITY(U,$J,358.3,25540,0)
 ;;=98962^^137^1543^5^^^^1
 ;;^UTILITY(U,$J,358.3,25540,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25540,1,2,0)
 ;;=2^98962
 ;;^UTILITY(U,$J,358.3,25540,1,3,0)
 ;;=3^Self-Mgmt Educ/Train 5-8 Pt
 ;;^UTILITY(U,$J,358.3,25541,0)
 ;;=90887^^137^1544^1^^^^1
 ;;^UTILITY(U,$J,358.3,25541,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25541,1,2,0)
 ;;=2^90887
 ;;^UTILITY(U,$J,358.3,25541,1,3,0)
 ;;=3^CONSULTATION WITH FAMILY
 ;;^UTILITY(U,$J,358.3,25542,0)
 ;;=90846^^137^1544^2^^^^1
 ;;^UTILITY(U,$J,358.3,25542,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25542,1,2,0)
 ;;=2^90846
 ;;^UTILITY(U,$J,358.3,25542,1,3,0)
 ;;=3^FAMILY PSYTX W/O PATIENT
 ;;^UTILITY(U,$J,358.3,25543,0)
 ;;=99401^^137^1544^3^^^^1
 ;;^UTILITY(U,$J,358.3,25543,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25543,1,2,0)
 ;;=2^99401
 ;;^UTILITY(U,$J,358.3,25543,1,3,0)
 ;;=3^Preventive Counseling, IND (15 Mins)
 ;;^UTILITY(U,$J,358.3,25544,0)
 ;;=99402^^137^1544^4^^^^1
 ;;^UTILITY(U,$J,358.3,25544,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25544,1,2,0)
 ;;=2^99402
 ;;^UTILITY(U,$J,358.3,25544,1,3,0)
 ;;=3^Preventive Counseling, IND (30 Mins)
 ;;^UTILITY(U,$J,358.3,25545,0)
 ;;=99403^^137^1544^5^^^^1
 ;;^UTILITY(U,$J,358.3,25545,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25545,1,2,0)
 ;;=2^99403
 ;;^UTILITY(U,$J,358.3,25545,1,3,0)
 ;;=3^Preventive Counseling, IND (45 Mins)
 ;;^UTILITY(U,$J,358.3,25546,0)
 ;;=99404^^137^1544^6^^^^1
 ;;^UTILITY(U,$J,358.3,25546,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25546,1,2,0)
 ;;=2^99404
 ;;^UTILITY(U,$J,358.3,25546,1,3,0)
 ;;=3^Preventive Counseling, IND (60 Mins)
 ;;^UTILITY(U,$J,358.3,25547,0)
 ;;=99411^^137^1544^7^^^^1
 ;;^UTILITY(U,$J,358.3,25547,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25547,1,2,0)
 ;;=2^99411
 ;;^UTILITY(U,$J,358.3,25547,1,3,0)
 ;;=3^Preventive Counseling, Group (30 Mins)
 ;;^UTILITY(U,$J,358.3,25548,0)
 ;;=99412^^137^1544^8^^^^1
 ;;^UTILITY(U,$J,358.3,25548,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25548,1,2,0)
 ;;=2^99412
